Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone on this board a while ago mentioned it seems as if the company is being run as a "hobby". Now I think that way too.
Plus, some people are making a living working there and others are making money through "financial transactions". It stinks.
3-Month Sales jump $1,281,889 and Net Loss only improves by $9,736; come on, really?
Few in your life will ever live up to your standards if you feel it is better to be judgmental of others with less time, knowledge, experience or sophistication.
It is always better to help others rise and continue on your own personal path as a leader, then to feel better about yourself by knocking others down.
There is never a stupid question when one decides they have a need to ask it. Character is shown in how one answers it or chooses not to.
Viking is an enigma. It's been around for years with middling success and disappointments. Now they are betting the company's future on a new product before they know there is a demand for it. If a big medical product manufacturer thought Viking's product and patents were the best, and there was a demand for it, they would scoop up the company. Maybe the Clinton Group is the first indication that it's a real possibility it might happen. The U.S. market that seemingly can afford it the most, seems to be the least interested. I wonder why? If the U.S. distributors aren't getting the job done, fire them at the first contractually allowable moment, and bringing in a distributor that can get it done. If their geographic territory is too vast for them to be effective, reallocate the geography. U.S. distributors should be selling more systems than all other distributors. If the product is "that good" and a major surgical benefit, then sales should be ramping up in a big way. If doctors are looking at the product with positive buying inclinations, they should be buying the stock as well, as should the distributors. Given the share price and ease to purchase big stakes, people who should know better about the opportunities are "voting" with their money by not getting involved. After 9 months of demonstrations, there should be a few thousand people who have been exposed one way or another to the company and its products. If some of them were believers, 3-D sales should be ramping up fast and so should trading volume. What's puzzling is that if the product is so good, why are so few taking notice? Progress seems so slow now that the product is being demonstrated. Will hundreds of buyers wake up in the next 12 months, or is the 3-D product being reviewed as pretty ho-hum?
Am I wrong or does Cabo/Worldwide have non-exclusive distribution agreements with other companies for the same products?
DKAM is only a company Cabo has an interest in, so they will also sell his products. Is that right?
Wow, you like to make people fell stupid, worthless and lazy.
Wow, you like to make people fell stupid, worthless and lazy.
U.S. Sales?
Does anybody know if U.S. sales are supposed to be company direct, of if the intension is to sign up distributors as they are doing internationally?
If the former, I wonder how they are going to do the product demonstrations at any reasonable rate? If the latter, I wonder what the hold up is lining up distributors?
Bottom line question, I wonder why it seems as if U.S. end-user sales are on hold?
08/09/2011 ... it appears there was an unannounced delay to release the next report.
No surprise ... Many questions need answering ... I wonder if they will clearly be addressed ... and if the wait will be worth it.
I've been accumulating ... and can't imagine why it won't continue as it has since my radar found it in August 2009 when it was $4.30.
It's a slow, steady winner.
It will be a bright green week with huge volume the moment Worldwide's cash is used for advertising. Hopefully it starts with a campaign related to the Miss Rheingold contest.
Like any trader, I am looking for some exciting news about DKAM that will give it a big bounce.
If Cabo is in DKAM to make money from product sales Vs the printing press, then I am really excited. There will be some big bounces -- up and down.
He's not getting any of the preferred shares. That tells us something too.
I wrote DKAM off a long time ago as a good investment with long term promise. The R/S'es and dilution have and will continue to kill it for "longs".
I've resigned myself to DKAM not being a good long term "buy and hold" investment, but there are so many factors new management can introduce to the marketplace that can cause some big bumps.
Revenues are sexy. If the Cabo deal and Rheingold keep growing the top line, it's going to open traders' eyes.
Right now we don't know the specifics, but something is brewing.
Remember, I've been here since 2009. I was slow to catch on, but I get it.
Right now PK is either conning Cabo and trying to take his money too.
Or Cabo is conning PK and trying to take the company.
Or PK and Cabo are conning the shareholders.
Or PK and Cabo intend to increase shareholder value while making something of this POS.
If advertising starts and does not cease, that will be a tremdous sign that something positive is going on.
If advertising does not start, and there is no method for DKAM to sell Worldwide's products, it will be back to the same old POS.
If dilution cannot be stopped, it's the same old POS.
Much is going on with the insiders and I can only hope change for the better is brewing.
The only trend that matters; more buyer volume and a higher number of buyers Vs sellers. So far that's what is happening today.
It will be fun to watch if it continues.
MoneyGram International, Inc. (MGI) Tops Q2 Views
StreetInside.com
July 28, 2011 9:18 AM EDT
MoneyGram International, Inc. (NYSE: MGI) reported Q2 adjusted EPS of $0.08, $0.06 better than the analyst estimate of $0.02. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.32 million.
MoneyGram International, Inc. (MGI) Tops Q2 Views
StreetInside.com
July 28, 2011 9:18 AM EDT
MoneyGram International, Inc. (NYSE: MGI) reported Q2 adjusted EPS of $0.08, $0.06 better than the analyst estimate of $0.02. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.32 million.
MoneyGram International, Inc. (MGI) Tops Q2 Views
StreetInside.com
July 28, 2011 9:18 AM EDT
MoneyGram International, Inc. (NYSE: MGI) reported Q2 adjusted EPS of $0.08, $0.06 better than the analyst estimate of $0.02. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.32 million.
Money Talks.
Three things are possible.
1) PK is either taking Cabo for a ride.
2) Or Cabo bought into PK's printing press.
3) Or Cabo's team intends to really take DKAM to the next level and PK wants him to do it.
I think it is as simple as that.
When we see Mexcor is supposed to be selling Worldwide's products and they really begin to do so as evidenced by their increasing royalty payments, and advertising starts without interruption, I think we'll know it's #3. If dilution does not resume, the pps will only go up.
There will be new found hope.
Too few care about the news. As commercialization happens and revenues start coming in, more people will start following AEN. They will regret not having found it sooner.
As for anyone's concern about more dilution, don't fret. Those past private placements were far above the present stock price and well worth the cash infusion to all of us. The O/S is still a meager 28 million. Smart money will be drawn to this company's management.
AEN is obviously committed to increasing shareholder value. They're capitalizing the company correctly, and steadily moving towards profitability with products that will have a recurring revenue stream.
I am saying the insiders can unanimously agree to further increase the A/S (before and or after a R/S any number of times). The BofD can also authorize a legal compensation package for Cabo so that he receives shares to avoid diluting his position.
If they sink "real money" into advertising, and continue it without end, then they will make me a believer again.
They won't do that without a distribution network in place. So I also want to know about the Mexcor relationship. If it does or does not exist anymore, and if it doesn't, who is going to be selling Worldwide's products for DKAM?
The questions that really should be asked are:
1) What operational changes are going to happen with the addition of Cabo and his team?
2) Does Cabo intend to move DKAM forward, or was he looking for a way in to a public company and its share printing press?
The actions we see them take over the next few months will answer these questions.
The surest indication will be if they invest cash to start and continue a retail product advertising campaign.
Since they won't make any money quickly, I'll believe they are serious and in it for the long haul if advertising starts and doesn't stop.
Anyone who sees that happening is going to be buying DKAM and drive the share price up, as long as it doesn't happen as new shares are being dumped.
The argument that dilution is over doesn't take into account that all of the insiders can agree to further increase the A/S with or without a R/S. It only takes their accent.
As long as PK owns the majority of the voting preferred shares, those are really the only ones that matter. The common shares are just blank pieces of paper they print and issue to raise cash. The part of Cabo's deal regarding the 49% can be satisfied by issuing him more shares in a suitable and legal manner to maintain that percentage while the remainder gets dumped to raise cash.
I bought at 21¢ and sold at 19¢ after the R/S announcement. So I suffered little damage and did it because I don't believe an R/S is ever good for existing shareholders of small companies.
I think CUGI is a good company with excellent potential, but generally feel that an R/S for companies like this leads to downward price pressure after the R/S. For emotional and fundemental reasons, the PPS can often times drop all the way back to pre split levels.
When a company isn't making money with 100,000 outstanding shares, they're still not making money after a 1 for 10 split and only have 10,000 outstanding shares.
If the stock isn't widely followed, which this one is not, the share price doesn't have support at the post R/S share price, so it drops.
If I miss out, so be it. I can't win them all. But I will wait to buy back in post R/S.
Baileyuk, your answer skips over a few dots that need connecting.
Except for Rheingold, none of the other "deals" you noted even mattered even when they were announced.
Mexcor is the last known national liquor selling agent for DKAM. PK made the Rheingold deals. If not for Mexcor, who is supposed to sell Worldwide's products on a national scale?
We should all care who is going to get that job done. If Mexcor is "out", then who is "in"?
When retail advertising hits "big markets", that's when the PPS is going up. Nothing else is going to spur significant interest.
900,000,000?
Was/is the A/S being upped to 900,000,000?
Re "Worldwide funding advertising": I'll believe it when I see it.
cargo_hauler Share Tuesday, July 26, 2011 2:32:00 PM
Re: FUNMAN818 post# 62776 Post # of 62785
Did you really read the last 3 SEC filings? My gut feeling is you did not!
Read them, all of them. You will see that Worldwide is funding advertising.
Worldwide is trading inventory for shares to establish a working capital for DKAM.
There is an anti-dilution clause for 1 year!
There also is NO AUTHORIZED SHARES LEFT... On July 13th there were 493 million out of 500 million authorized shares, outstanding.
Most all of the new shares go to Worldwide....
Dilution is done. Read the filings!
$100,000 - $150,000 ... it's nice to learn the end-user price range. I am looking forward to the next sales report, and learning when domestic sales begin. The 6 - 9 month selling period is closing in on 9 months.
Evidence Removed.
Why would dilution end? PK's "insider purchases" which used to be displayed on this page indicated to me that they were all for show since he knew those "buys" would propel greater income through dilution. That's what made it a good investment. Not that he thought the share price would rise. It was a move to lure "suckers".
Why would Worldwide care about their shares devaluing through dilution, if they realize they have a magical cash register at their disposal that always has another dollar in it after the last one was removed. PK already proved to them that the formula worked for him.
Do you believe that DKAM is going to start paying "cash" for products and services?
No way; bartering shares for products and services must continue.
When we see the next 10Q, after the much anticipated notice of its delayed release, hopefully we get all the answers about the Mexcor status, and get a better handle on where Rheingold revenues are going.
My guess is that those numbers will be uninspiring. If there is an upside surprise, you can beat there will be further dilution to capitalize on the news.
Castle Brands Receives Notice from the NYSE AMEX Relating to Failure to Conduct Annual Shareholder Meeting During Fiscal 2011
2011-07-08 17:03 ET - News Release
You would think with Dr. Frost involved, something like this would never happen.
NEW YORK -- (Business Wire)
Castle Brands Inc. (NYSE Amex: ROX), a developer and international marketer of premium beverage alcohol brands, today disclosed receipt of a notice from the NYSE Amex, LLC ("NYSE Amex" or "Exchange"), dated July 5, 2011. The notice states that Castle Brands is not in compliance with Section 704 of the NYSE Amex Company Guide ("Company Guide") in that it failed to hold an annual shareholder meeting within one year after the Company’s fiscal year ended March 31, 2010.
Castle Brands has submitted a plan of compliance to the NYSE Amex advising the Exchange of actions the Company intends to take to regain compliance with Section 704 of the Company Guide prior to the January 5, 2012 deadline set by the NYSE Amex. The plan states that Castle Brands expects to hold a meeting of its shareholders in September 2011, thereby bringing the Company into compliance with Section 704.
The Company's trading symbol will continue to be "ROX", however, the extension .BC will be appended on the Consolidated Tape Association's Consolidated Tape System and Consolidated Quote System until the Company regains compliance with the Exchange's requirements.
About Castle Brands Inc.
Castle Brands is a developer and international marketer of premium beverage alcohol brands including: Gosling's Rum®, Jefferson's®, Jefferson's Presidential SelectTM and Jefferson's Reserve® Bourbon, Boru® Vodka, Pallini® Limoncello, Raspicello and Peachcello, Knappogue Castle Whiskey®, Clontarf® Irish Whiskey, Betts & SchollTM wines, cc: winesTM, Celtic Crossing® Liqueur, Brady's® Irish Cream, A. De Fussigny® cognacs, Travis Hasse's Original®Liqueurs and TierrasTM tequila. Additional information concerning the Company is available on the Company's website,
Does anyone need a laugh?
How Penny Stocks work -
Neither Mexcor or DKAM replied to my questions regarding the status of their ongoing agreement.
Anyone need a laugh?
How Penny Stocks work -
SFIO's biggest problem is cash.
Another common "Pink Practice" is that companies barter shares at a premium in lieu of cash, in exchange for products and services from suppliers.
If those shares can not be quickly redeemed in the open market, whatever products and services were being provided, cease being provided.
SFIO's management is scrambling now. Expecting them to put out a PR with all of the answers, this quickly is not reaseaonable. They are short key players who shouldered responsibilities that are now in other hands.
Those who remain are in the middle of determining how they are going to fund the company and "keep the doors open". Their business is definately not operating as usual.
Dilution happens in many forms in small companies. If their standard and most reliable funding source (the open market) is choked off, they need to find a "deep pocket".
They're in debt up to their eyeballs and beyond, it's not going to be easy.
Virtually everything was funded through dilution between 2009 and the introduction of the REAL. The dilution is in the historical records.
So are the very large loans they took out two years ago and last year. Only problem is those monies went towards keeping the company in business paying salaries and ongoing expenses, not towards selling the REAL and generating revenues.
It's not unexpected that Pinks fund themselves by diluting; most do. So to say it is not going to continue once they can start doing it again is not being realistic.
They need cash to pay for product, salaries and operations. Revenues are not going to cover that, only dilution can.
Sub .009 here we come. Until there is certainty the company will continue to exist and be able to fund itself without shenanigans, there is only one direction SFIO can go.
They have to overcome their cash short-falls just to operate, pay salaries, and then find more money to advertise and compete.
SFIO has not been magically funded by revenues. Only dilution could generate money for salaries and other expenses. If anyone does not believe dilution funded that, then they can explain where the money came from. Otherwise, when the dilution machine can be restarted, it will be and then a R/S will be inevitable.
Once all the hype vanishes from the REAL finally being introduced, reality will set in, and that will be the fundamentals cannot support penny-land prices.
Until management can explain how they are reorganizing themselves, move beyond the taint that spread all over them, and show they are grabbing a real chuck of the market share with visible advertising, SFIO will drift well below .009 and only reach a bottom when some diehards just won't let go.
WTF ... ARE THEY KIDDING !?!?!?!?!?
Another R/S?
And then they're going to issue Incentive Plan shares to themselves.
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On June 30, 2011, we held a special meeting of stockholders. At the meeting, our stockholders approved separate amendments to our certificate of incorporation that would effect a reverse split of our common stock within a range of 1:2 to 1:10, and authorized our board of directors to determine the ratio at which the reverse split will be effected by filing the appropriate amendment to our certificate of incorporation. Out of 26,826,157 shares of our common stock outstanding as of the record date for the special meeting, holders of shares of our common stock cast 17,813,134 votes for the proposal and 96,686 votes against the proposal, 67,480 votes abstained and there were no broker non-votes.
Our stockholders also approved at the meeting an amendment to our 2006 Stock Incentive Plan, previously approved by our board of directors, which increased the number of shares of our common stock authorized for issuance thereunder to 7,000,000. Holders of shares of our common stock cast 16,372,477 votes for this proposal and 1,468,142 votes against this proposal, 136,681 votes abstained and there were no broker non-votes.
BTW, if I was sure of the fundamental changes that will take place I would own a hedge fund.
Based on some of what I already wrote, here's why I think there will be more than 70 end user units sold by Dec 31, 2012.
1) I don't think things cannot fundamentally change. VKNG is showing good follow through.
2) It makes sense that more presentations per demo unit will be given in the 20th month than were given in the 10th month.
3) It makes sense that more distributors will be added ... internationally ... and once the domestic market is opened up.
4) As more docs use the product and provide positive testimonials, more docs will want it. Buyers' resistance will decrease.
5) Selling the first 50 end user systems will be harder than selling the second 50 systems, and so on.
6) As more docs want it, more distributors will want it too.
Taken as a whole, things should improve. I cannot predict by how much.
At the moment, I have no idea why the share price is so steady. It seems to me that it should be much lower now, so I have no future share price predictions.
As demo units rise and per demo unit sales rise, I will be a buyer of VKNG. For now I own enough of it.
ssc Share Friday, July 08, 2011 9:21:08 AM
Re: FUNMAN818 post# 3780 Post # of 3781
Thanks for the time and effort you put into that reply. I won't get into everything I disagree with, but I will go on record as saying that if by the end of 2012 there have been only 70 units sold in total since the introduction of the product, the stock price will be under 10 cents and the future survival of the company will be in jeopardy.
I wrote that a great goal is one end user sale per quarter per demo unit, not per distributor.
I also implied that if fundamentally nothing changes, the results should not change, hence my guesstimate of 70 units sold at the end of the first 24/25 months of full year sales (Dec 31, 2012).
Capacity has nothing to do with sales results.
If the existing distributors are going to sell just a little more than 1 unit per quarter, without other factors improving their results, then VKNG has to focus on increasing their own global reach. That's the only thing they can control.
To attain 50 sales per month, your figure of (about) 150 distributors very well may be correct.
It is my opinion that product demonstations are far more complex than you believe. Fewer can be given than you want them to do every day, and buyers have to learn more about 3D before they want it, and that's long before they buy it. So it makes sense that more presentations per demo unit will be given in the 20th month than were given in the 10th month.
I also think it is easier to add distributors than it is to force more sales per demo unit.
The number of distrubutors will also jump when domestic distributors are signed up.
So if any combination of more distributors and more demo units add up to 150, it's likely to be a fail safe "results" system for 50 sales per month, and VKNG will become a penny stock that roared.
If distributors can increase the number of sales per demo unit above the present rate, it's a bonus.
I agree it's reasonable to assume as more prospects are put into the pipeline and product testimonials increase, distributor results per demo unit should increase.
ssc Share Thursday, July 07, 2011 11:10:51 PM
Re: FUNMAN818 post# 3778 Post # of 3779
So what did I misread? I said 1 sale/quarter/distributor would be ludicrous 18 months from now.
Also, why would you expect to only have sold 70 units by 12/31/2012? Are you totally dismissing the CEO's statement that he wanted to ramp up production capabilities to handle 50 units/month by the end of this year?
Agreed, but several environmental things are different before this coming 10Q than the recent previous ones.
The biggest is that the potential subscription price increase that has motivated enthusiasm is put off. So that stimulus has been removed until the fall when it will once again be nearer to happening.
Previously we didn't have to deal with the "Japan shut-down" which directly effects auto production.
We haven't needed to adjust the nation's debt ceiling since Bush was in the White House, and SIRI was trading at about 50¢.
So the big potential news is that subscriptions "beat" the forecast in spite of all the negativity.
Right now, not "missing" is more important.
Between this coming 10Q and the next, everything is going to settle down, and used car activation subscriptions are going to be a much anticipated number.
2.0 is either going to "be here" or "just weeks away".
Before this coming 10Q, I don't see SIRI beating it's most recent "high", but you're right, it's probably going up from here.
So it's going to be October when SIRI has $3 in its sights.
I missed buying more during the last dip but won't miss again if it goes back down below $2.
We're in a holding pattern and won't move much; just my opinion.
Here's why:
Price increases are put off, used car reactivation figures won't be noticed until the fall, 2.0 is still a mystery (I wonder if they're waiting to introduce it as a Christmas-time promotion), Japan went "off-line", as the share price ramps up the P/E is becoming more noticeable, and the U.S. Government can't agree on a "debt ceiling".
So, until some of these things shake-out, and/or the 10Q comes out and we see some "beats", IMHO we're not moving much from here until the fall. That's when the "rate increase" hype will gain traction again.
I think we'll be heading into the $3's this fall.
You too misread what I wrote ... "1 end user sale per quarter per demo unit in my opinion would be a very nice 18 month benchmark to reach. It would be a great accomplishment."
Right now they need to almost triple the sales per demo unit to reach that pace.
In an earlier post I also noted there are only 28 demo units right now. They either need more distributors and/or for existing distributors to buy more demo systems to reach 50 demo units.
At the present rate of sales they are on track for about 35 end user sales by the end of the first full 12 month year. Assuming nothing else changes, I see no reason why about 70 end user sales by Dec 31, 2012 isn't where we will find ourselves.
Those will also all be international sales.
As for the number of demos each distributor can do, IMHO I believe you are underestimating the complexity of a complete demonstration which I assume may include on the buyers' side any combination of multiple surgeons, surgical nurses, administrators, buyers, and maybe board of director members.
I used to sell copiers to "large accounts" in Philadelphia metro. Often times I had entire department staffs in attendance when I did a demonstration as well as department heads, plus the person who was responsible to sign the sales contract. If I did 5 demos in a week I was a hero.
The 3D demonstrations have to be way more mechanically and intellectually complex.
No hospital will spend $100,000 frivolously. Some of the staff has to want it first. The sales process might take multiple presentations too.
Another thing to put potential prospects into perspective, I did a goggle check to learn of the number of hospitals in the U.S.
I found this:
Total Number of All U.S. Registered Hospitals 5,759
Total Staffed Beds in All U.S. Registered Hospitals 955,768
Source:
American Hospital Association: Fast Facts on U.S. Hospitals from AHA
Hospital Statistics
http://www.aha.org/aha/resource_center/fastfacts/fast_facts_US_hospitals.html
It's my opinion that there are fewer hospitals in existing VKNG distributor areas (per capita) than in the U.S.
It is also my opinion that it is more difficult to get people in those hospitals where funds are less available than here, to reach the tipping point when their budgets will allow them to investigate a 3D purchase than you may want to think.
There are also competitive distributors selling all kinds of things to these hospitals; all seeking the very same ears of everyone who is able to buy their products.
My conclusion is that rather than forcing triple the sales per demo unit than is currently happening, VKNG should focus on what's more controllable, which is signing up more distributors in more parts of the world.
I would like to take the path of least resistance and pick the lower hanging fruit. Expanding "reach" is easier and gets us the same results.
I am wondering if DKAM really did get a 3rd party loan and if that party knew all about the Cabo deal and his background?
There is nothing about the loan at:
http://www.nasdaq.com/aspxcontent/newsheadlines.aspx?symbol=DKAM&selected=DKAM&SourceCode=PMZ
I can't find anything about the loan anywhere in "the news" or on DKAM's web site. I'm not talking about the CABO deal/investment. I am talking about the 3rd party Senorita had been referring to.
I sent questions to Mexcor and DKAM asking if the Drinks America Joint Venture Production and Distribution Agreement is still in full effect, and if no, what the status is.
It will be interesting to see if I get a response, and if I do, what we learn.
If the 3rd party lender exists and knew everything about Cabo, and if the Mexcor agreement is in full effect, now I am wondering if there is a new business plan in the works?
Or are there just more fingers in the dilution till?
I too am interested to read all about what's going on in the 10Q.
Most amazing was how much of the current problems may have been predicted. Many of management's prior history of criminal activities (charged, fined, or not prosecuted) were fully revealed by many of the posters on this board a year ago.
Some posters denied, ignored, shot down or accused those who were doing serious background checks as being libelous.
The past facts are unalterable. Anyone can dig up the facts again.
It took more than a year for the law to catch up to these guys. Like a tiger, they could not change their strips.
Hopefully they will go to jail and not be able to hurt people ever again.
However this gets resolved, if SFIO can remain in business, shareholders will end up suffering through a R/S and more dilution. It has to happen.
The T/A is gagged, but dilution has been rampant. Some of those shares may have been illegally sold. So whenever the shakeout finally happens, SFIO will still be out of cash. They'll have to resume their SOP and restart diluting after they do a R/S. It will be their only source of positive cash flow.
News? Has anyone heard anything that can be stimulating today's early trading volume?